Galit Alter
Born1976 or 1977 (age 46–47)[1]
EducationPh.D. from McGill University[2]
AwardsMGH Research Scholars Award (twice)[3]
Scientific career
Fieldsimmunology, infectious diseases
InstitutionsHarvard Medical School
Ragon Institute
Websiteragoninstitute.org/portfolio-item/alter-lab/

Galit Alter is an immunologist and virologist, professor of medicine at Harvard Medical School, and group leader at the Ragon Institute of MGH, MIT and Harvard. She is known for her work on the expansion of particular natural killer cell subtypes in response to HIV-1 infection.[4][5] She has also contributed to the understanding of how SARS-CoV-2 antibody titers correlate with sustained humoral protection, including identifying coordinated immune cell-antibody signatures that may predict COVID-19 infection outcome.[1][6]

References

  1. 1 2 Scanlon, Jessie (2020-12-10). "Galit Alter: Connecting scientists to speed up the COVID-19 fight". bostonglobe.com. Retrieved 2021-02-23.
  2. ↑ "Virology Faculty Member - Galit Alter". hms.harvard.edu. Retrieved 2021-02-23.
  3. ↑ "Alter - Ragon Institute of MGH, MIT and Harvard". ragoninstitute.org. Retrieved 2021-02-23.
  4. ↑ Alter, Galit; Malenfant, Jessica M; Altfeld, Marcus (2004). "CD107a as a functional marker for the identification of natural killer cell activity". J Immunol Methods. 294 (1–2): 15–22. doi:10.1016/j.jim.2004.08.008. PMID 15604012. Retrieved 1 April 2021.
  5. ↑ Alter, Galit; Martin, Maureen P; et al. (26 Nov 2007). "Differential natural killer cell-mediated inhibition of HIV-1 replication based on distinct KIR/HLA subtypes". J Exp Med. 204 (12): 3027–36. doi:10.1084/jem.20070695. PMC 2118524. PMID 18025129.
  6. ↑ Atyeo, Caroline; Fischinger, Stephanie; Zohar, Tomer...; Alter, Galit (15 September 2020). "Distinct Early Serological Signatures Track with SARS-CoV-2 Survival". Immunity. 53 (3): 524–532. doi:10.1016/j.immuni.2020.07.020. PMC 7392190. PMID 32783920.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.